AIM Vaccine Co., Ltd. (6660.HK)
HKD 3.5
(6.38%)
HKD 3.5
(6.38%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Cash Flow | -165.49 Million | -110.31 Million | 93.39 Million | 250.33 Million | - |
| Net Income | -2.27 Billion | -434.16 Million | -606.7 Million | 485.88 Million | - |
| Depreciation & Amortization | 174.69 Million | 166.44 Million | 144.29 Million | 128.34 Million | - |
| Deferred income taxes | - | - | - | - | - |
| Stock-based compensation | -14.2 Million | 225.76 Million | 952.12 Million | 23.47 Million | - |
| Change in working capital | 111.77 Million | -76.6 Million | -327.43 Million | -339.19 Million | - |
| Other non-cash items | 27.84 Million | 10.33 Million | -5 Million | 1.6 Million | - |
| Investing Cash Flow | -271.95 Million | -858.15 Million | -1.33 Billion | -604.91 Million | - |
| Investments in PPE | -301.64 Million | -856.64 Million | -1.14 Billion | -667.01 Million | - |
| Acquisitions | - | - | -250.37 Million | - | - |
| Investment purchases | - | -160 Million | - | - | -50 Million |
| Sales/Maturities of investments | 8.12 Million | 103.07 Million | 5.9 Million | 51.31 Million | - |
| Other Investing Activities | 7.94 Million | 47.17 Million | 37.89 Million | -2.69 Million | - |
| Financing Cash Flow | 362.06 Million | 980.37 Million | 788.01 Million | 1.13 Billion | - |
| Debt repayment | -430.59 Million | -847.85 Million | -293.32 Million | -110.01 Million | - |
| Dividends payments | - | - | - | - | -86 Million |
| Common Stock Repurchased | - | - | - | - | - |
| Common Stock Issuance | - | 162.01 Million | 553.47 Million | 519.77 Million | - |
| Other Financing Activities | -5 Million | 15 Million | - | 761.9 Million | -142.1 Million |
| Accounts receivables | 43.04 Million | - | - | - | - |
| Accounts payables | - | - | - | - | - |
| Inventory | -15.64 Million | -161.99 Million | -136.35 Million | -30.48 Million | - |
| Other working capital | 84.37 Million | - | - | - | - |
| Cash at beginning of period | 656.26 Million | 646.74 Million | 1.1 Billion | 318.63 Million | - |
| Cash at end of period | 583.14 Million | 656.26 Million | 646.74 Million | 1.1 Billion | - |
| Capital Expenditure | -301.64 Million | -856.64 Million | -1.14 Billion | -667.01 Million | - |
| Effect of forex changes on cash | 2.26 Million | -2.37 Million | - | - | - |
| Net cash flow / Change in cash | -73.12 Million | 9.52 Million | -456.08 Million | 784.19 Million | - |
| Free Cash Flow | -467.14 Million | -966.95 Million | -1.04 Billion | -416.68 Million | - |
| Breakdown | 2024 Q2 | 2023 FY | 2023 Q4 | 2023 Q2 | 2022 Q4 | 2022 FY |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -139.25 Million | -2.27 Billion | -1.05 Billion | -250.36 Million | -274.72 Million | -434.16 Million |
| Depreciation & Amortization | 92.28 Million | 174.69 Million | 83.86 Million | 90.82 Million | 87.77 Million | 166.44 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | -14.2 Million | 7.65 Million | -21.85 Million | 164.15 Million | 225.76 Million |
| Change in working capital | -41.52 Million | 111.77 Million | 130.83 Million | -5.56 Million | 7.02 Million | -76.6 Million |
| Other non-cash items | -8.65 Million | 27.84 Million | 911.78 Million | -62.04 Million | -18.35 Million | 10.33 Million |
| Investing Cash Flow | -91.53 Million | -271.95 Million | -192.41 Million | -79.54 Million | -557.5 Million | -858.15 Million |
| Investments in PPE | -50.63 Million | -301.64 Million | -77.94 Million | -80.97 Million | -343.65 Million | -856.64 Million |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | -160 Million |
| Sales/Maturities of investments | - | 8.12 Million | - | - | - | 103.07 Million |
| Other Investing Activities | -40.89 Million | 7.94 Million | -114.47 Million | 1.43 Million | -213.85 Million | 47.17 Million |
| Financing Cash Flow | 130.44 Million | 362.06 Million | 102.18 Million | 259.88 Million | 533.14 Million | 980.37 Million |
| Debt repayment | -160.32 Million | -430.59 Million | - | -283.83 Million | - | -847.85 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | 162.01 Million |
| Other Financing Activities | -29.88 Million | -5 Million | 102.18 Million | -23.94 Million | 533.14 Million | 15 Million |
| Accounts receivables | -92.89 Million | - | 46.82 Million | -3.47 Million | 42.19 Million | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | 18.72 Million | -15.64 Million | 32.33 Million | -47.97 Million | -63.93 Million | -161.99 Million |
| Other working capital | 32.64 Million | - | 51.67 Million | 45.87 Million | 28.76 Million | - |
| Cash at beginning of period | 583.14 Million | 656.26 Million | 589.89 Million | 656.26 Million | 717.14 Million | 646.74 Million |
| Cash at end of period | 525.34 Million | 583.14 Million | 583.14 Million | 589.89 Million | 656.26 Million | 656.26 Million |
| Capital Expenditure | -50.63 Million | -301.64 Million | -77.94 Million | -80.97 Million | -343.65 Million | -856.64 Million |
| Effect of forex changes on cash | 445 Thousand | 2.26 Million | -15 Thousand | 2.28 Million | -2.37 Million | -2.37 Million |
| Net cash flow / Change in cash | -57.8 Million | -73.12 Million | -6.74 Million | -66.37 Million | -60.87 Million | 9.52 Million |
| Free Cash Flow | -147.79 Million | -467.14 Million | 5.55 Million | -329.97 Million | -377.78 Million | -966.95 Million |
PIAGF
2877
APPZ
SIMH3
CAVEN
SCHB